Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitis

Kidney International

Volumn 62, Issue 5, 2002, Pages 1806-1818

  Yekebas, Emre F ^a,b   Strate, Tim ^a,b   Zolmajd, Sharam ^a,b   Eisenberger, Claus F ^a,b   Erbersdobler, Andreas ^a,b   Saalmöller, Armin ^a,b   Steffani, Katharina ^a,b   Busch, Christoph ^a,b   Elsner, Holger Andreas ^a,b   Engelhardt, Madelaine ^a,b   Gillesen, Andrea ^a,b   Meins, Jan ^a,b   The, Marcel ^a,b   Knoefel, Wolfram T ^a,b   Izbicki, Jakob R ^a,b  

^a Medical Microbiology/Immunol Inst   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Hemofiltration; Immunology; Inflammation; Multiple organ dysfunction; Necrotizing pancreatitis; Organ failure; Pancreatogenic sepsis

Indexed keywords

CD14 ANTIGEN; ENTEROPEPTIDASE; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENDOTOXEMIA; FEMALE; HEMOFILTRATION; MALE; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS; SURVIVAL; SWINE; VASCULAR RESISTANCE;

EID: 18644385592     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00607.x     Document Type: Article

References (44)

1. Gotloib L, Barzilay E, Shustak A, Lev A: Sequential hemofiltration in nonoliguric high capillary permeability pulmonary edema of severe sepsis: Preliminary report. Crit Care Med 12:997-1000, 1984
2. Gotloib L, Barzilay E, Shustak A, et al: Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation 13:123-132, 1986
3. Gotloib L, Shostak A, Lev A, et al: Treatment of surgical and non-surgical septic multiple organ failure with bicarbonate hemodialysis and sequential hemofiltration. Intensive Care Med 21:104-111, 1995
4. Barzilay E, Kessler D, Berlot G, et al: Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. Crit Care Med 17:634-637, 1989
5. Gomez A, Wang R, Unruh H, et al: Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 73:671-685, 1990
6. Yekebas EF, Treede H, Knoefel WT, et al: Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann Surg 229:514-522, 1999
7. Bellomo R, Tipping P, Boyce N: Continuous venovenous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21:522-526, 1993
8. Guice KS, Oldham KT, Johnson KJ, et al: Pancreatitis-induced acute lung injury. An ARDS model. Ann Surg 208:71-77, 1988
9. Willemer S, Feddersen CO, Karges W, Adler G: Lung injury in acute experimental pancreatitis in rats. I. Morphological studies. Int J Pancreatol 8:305-321, 1991
10. Feddersen CO, Willemer S, Karges W, et al: Lung injury in acute experimental pancreatitis in rats. II. Functional studies. Int J Pancreatol 8:323-331, 1991
11. Berry AR, Davies GC: Millar AM, Taylor TV. Changes in the biophysical properties and ultrastructure of lungs, and intrapulmonary fibrin deposition in experimental acute pancreatitis. Gut 24:929-934, 1983
12. Curley P, Nestor M, Collins K, et al: Decreased interleukin-2 production in murine acute pancreatitis: Potential for immunomodulation. Gastroenterology 110:583-588, 1996
13. Norman J, Franz M, Messina J, et al: Interleukin-1 receptor antagonist decreases severity of acute experimental pancreatitis. Surgery 117:648-655, 1994
14. Heath DL, Cruickshank DH, Gudgeon M, et al: Role of interleukin-6 in mediating the acute phase protein response and potential as an early means in acute pancreatitis. Pancreas 66:41-45, 1993
15. Gross V, Andreesen R, Leser HG, et al: Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 22:200-203, 1992
16. Richter A, Nebe T, Kattermann R, Trede M: Immune paralysis in acute pancreatitis-HLA-DR antigen expression on CD14+DR+ monocytes. Langenbecks Arch Chir 381:38-41, 1996
17. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992
18. Bone RC: Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452-3455, 1992
19. Schroedl W: Diagnostische Verwendbarkeit Ausgewählter Immunologischer Parameter in Seren von Schweinen und Pferden. Doctoral thesis, University of Leipzig, Germany, 1994
20. Murtaugh M: Porcine cytokines. Vet Immunol Immunopathol 43:37-44, 1994
21. Schmidt J, Rattner DW, Lewandrowski K, et al: A better model of acute panceatitis for evaluating therapy. Ann Surg 215:44-56, 1992
22. Saalmueller A, Weiland E, Reddehase MJ: Resting porcine T lymphocytes expressing class II major histocompatibility antigen. Immunobiology 183:102-114, 1991
23. Gebhardt C, Bödeker H, Blinzler L, et al: Wandel in der therapie der schweren akuten pankreatitis. Chirurg 65:33-41, 1994
24. Ronco C, Tetta C, Lupi A, et al: Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 23:99-107, 1995
25. Rogiers P, Zhang H, Smail N, et al: Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-α attenuation during endotoxic shock. Crit Care Med 27:1848-1855, 1999
26. Sander A, Armbruster W, Sander B, et al: Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med 23:878-884, 1997
27. Van Bommel EF, Hesse CJ, Jutte NH, et al: Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome. Renal Fail 19:443-454, 1997
28. De Vriese A, Colardyn FA, Philippe JJ, et al: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 10:846-853, 1999
29. Storck M, Hartl WH, Zimmerer E, Inthorn D: Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 337:452-455, 1991
30. Ronco C, Bellomo R, Homel P, et al: Effect of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356:26-30, 2000
31. Hershman M J, Cheadle WG, Wellhausen SR, et al: Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 77:204-207, 1990
32. Birkenmaier C, Hong YS, Horn JK: Modulation of the endotoxin receptor (CD14) in septic patients. J Trauma 32:473-479, 1991
33. Lin RY, Astiz ME, Saxon JC, Rackow EC: Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CDllb, CD14, and IL-2R expression. Chest 104:847-853, 1993
34. Volk HD, Reinke P, Krausch D, et al: Monocyte deactivation rationale for a new therapeutic strategy in sepsis. Intensive Care Med 22:474-481, 1996
35. McCall CE, Grosso-Willmoth LM, LaRue K, et al: Tolerance to endotoxin-induced expression of the interleukin-lβ gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 91:853-861, 1993
36. 51C-labeled lipid A before and after the induction of endotoxin tolerance. Proc Natl Acad Sci USA 81:3491-3495, 1984
37. Bean AGD, Freiberg RA, Andrade S, et al: Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect Immun 61:4937-4939, 1993
38. Howard M, Muchamel T, Andrade S, Menon S: Interleukin 10 protects mice from lethal endotoxaemia. J Exp Med 177:1205-1208, 1993
39. Kusske AIM, Rongione AJ, Reber HA: Cytokines and acute pancreatitis. Gastroenterology 110:639-642, 1996
40. Van Laethem JV, Marchant A, Delvaux A, et al: Interleukin 10 prevents necrosis in murine experimental pancreatitis. Gastroenterology 108:1917-1922, 1995
41. Gudgeon AM, Heath DI, Hurley P, et al: J Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 335:4-8, 1990
42. Beger HG, Bittner R, Block S, Buechler M: Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 91:433-438, 1986
43. Banks PA: Infected necrosis: Morbidity and therapeutic consequences. Hepatogastroenterology 38:116-119, 1991
44. Uhl W, Schrag HJ, Wheatley AM: The role of infection in acute pancreatitis. Dig Surg 11:214-219, 1994